{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:54:52Z","timestamp":1781567692157,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2022005B"],"award-info":[{"award-number":["JNL-2022005B"]}]},{"name":"Shandong Provincial Laboratory Project","award":["SYS202202"],"award-info":[{"award-number":["SYS202202"]}]},{"name":"the National Key R&D Program of China","award":["2023YFC2506004"],"award-info":[{"award-number":["2023YFC2506004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45564-4","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:20:02Z","timestamp":1776813602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomics-based and functional validation to explore the effect of the gut microbe-associated metabolite guanidinoacetic acid on rectal adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Yulong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanhan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"45564_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66 (4), 683\u2013691 (2017).","journal-title":"Gut"},{"issue":"3","key":"45564_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. Cancer J. Clin. 73 (3), 233\u2013254 (2023).","journal-title":"Cancer J. Clin."},{"key":"45564_CR3","doi-asserted-by":"crossref","unstructured":"Kim, C. W., Shin, U. S., Yu, C. S. & Kim, J. C. Clinicopathologic Characteristics, Surgical Treatment and Outcomes for Splenic Flexure Colon Cancer. Cancer Res. Treatment 42(2). (2010).","DOI":"10.4143\/crt.2010.42.2.69"},{"issue":"S1","key":"45564_CR4","doi-asserted-by":"publisher","first-page":"s62","DOI":"10.1007\/s10151-004-0114-0","volume":"8","author":"D Kanellos","year":"2004","unstructured":"Kanellos, D. et al. Anaemia as a symptom of right colon cancer. Tech. Coloproctol. 8 (S1), s62\u2013s64 (2004).","journal-title":"Tech. Coloproctol."},{"key":"45564_CR5","unstructured":"Rolf Sauer, M. D. et al. M.D.,Heinz Schmidberger MD, and M.D., Group* ftGRCS: Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. The New England Journal of Medicine (2025)."},{"key":"45564_CR6","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Liu, X., Chen, D. & Yu, J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct. Target. Therapy 7(1). (2022).","DOI":"10.1038\/s41392-022-01102-y"},{"issue":"6","key":"45564_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/bjs\/znac050","volume":"109","author":"A Kothari","year":"2022","unstructured":"Kothari, A. et al. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient\/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br. J. Surg. 109 (6), 489\u2013492 (2022).","journal-title":"Br. J. Surg."},{"key":"45564_CR8","doi-asserted-by":"crossref","unstructured":"Xu, L. et al. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. Journal Hematol. & Oncology 15(1). (2022).","DOI":"10.1186\/s13045-022-01307-2"},{"key":"45564_CR9","doi-asserted-by":"crossref","unstructured":"Shamseddine, A. et al. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma. Radiation Oncology 15(1). (2020).","DOI":"10.1186\/s13014-020-01673-6"},{"issue":"11","key":"45564_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1158\/2326-6066.CIR-18-0174","volume":"6","author":"T Hamada","year":"2018","unstructured":"Hamada, T. et al. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunol. Res. 6 (11), 1327\u20131336 (2018).","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"45564_CR11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem, E. et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 27 (8), 1386\u20131422 (2016).","journal-title":"Ann. Oncol."},{"issue":"10","key":"45564_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12 (10), 661\u2013672 (2014).","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"45564_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Reviews Gastroenterol. Hepatol. 16 (11), 690\u2013704 (2019).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"issue":"6371","key":"45564_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science 359 (6371), 97\u2013103 (2018).","journal-title":"Science"},{"key":"45564_CR15","doi-asserted-by":"crossref","unstructured":"Xi, Y. et al. Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer. Journal Translational Medicine 17(1). (2019).","DOI":"10.1186\/s12967-019-2102-1"},{"key":"45564_CR16","doi-asserted-by":"crossref","unstructured":"Qu, R. et al. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Advanced Science 10(23). (2023).","DOI":"10.1002\/advs.202205563"},{"key":"45564_CR17","doi-asserted-by":"crossref","unstructured":"Nagavardhini Avuthu. a Chittibabu Gudaa b: Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer. (2022).","DOI":"10.1128\/spectrum.00013-22"},{"key":"45564_CR18","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Ling, Z. & Li, L. The Intestinal Microbiota and Colorectal Cancer. Frontiers Immunology 11. (2020).","DOI":"10.3389\/fimmu.2020.615056"},{"issue":"18","key":"45564_CR19","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/nar\/gkz569","volume":"47","author":"BJ Callahan","year":"2019","unstructured":"Callahan, B. J. et al. High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution. Nucleic Acids Res. 47 (18), e103\u2013e103 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"45564_CR20","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"45564_CR21","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"45564_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"45564_CR23","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. Journal Experimental & Clin. Cancer Research 42(1). (2023).","DOI":"10.1186\/s13046-023-02698-x"},{"issue":"1","key":"45564_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41588-021-00968-y","volume":"54","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat. Genet. 54 (1), 52\u201361 (2022).","journal-title":"Nat. Genet."},{"issue":"11","key":"45564_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41579-021-00569-w","volume":"19","author":"S Heilbronner","year":"2021","unstructured":"Heilbronner, S., Krismer, B., Br\u00f6tz-Oesterhelt, H. & Peschel, A. The microbiome-shaping roles of bacteriocins. Nat. Rev. Microbiol. 19 (11), 726\u2013739 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"45564_CR26","doi-asserted-by":"crossref","unstructured":"Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371(6536). (2021).","DOI":"10.1126\/science.abc4552"},{"issue":"7","key":"45564_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong, C. C. & Yu, J. Gut microbiota in colorectal cancer development and therapy. Nat. Reviews Clin. Oncol. 20 (7), 429\u2013452 (2023).","journal-title":"Nat. Reviews Clin. Oncol."},{"key":"45564_CR28","doi-asserted-by":"crossref","unstructured":"Huh, J-W. et al. Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer. Microbiome 10(1). (2022).","DOI":"10.1186\/s40168-022-01388-8"},{"key":"45564_CR29","doi-asserted-by":"crossref","unstructured":"G\u00fcle\u00e7 Ta\u015fk\u0131ran, A. E. et al. Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer. Translational Oncology 48. (2024).","DOI":"10.1016\/j.tranon.2024.102078"},{"issue":"2","key":"45564_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/em.20588","volume":"52","author":"KT Chung","year":"2011","unstructured":"Chung, K. T. & Gadupudi, G. S. Possible roles of excess tryptophan metabolites in cancer. Environ. Mol. Mutagen. 52 (2), 81\u2013104 (2011).","journal-title":"Environ. Mol. Mutagen."},{"key":"45564_CR31","unstructured":"Diane, F. et al. Effect of l-Tryptophan Excess and Vitamin B6 Deficiency on Rat Urinary Bladder Cancer Promotion. Cancer Research (2013)."},{"issue":"5","key":"45564_CR32","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.ajpath.2018.01.011","volume":"188","author":"EE Alexeev","year":"2018","unstructured":"Alexeev, E. E. et al. Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor. Am. J. Pathol. 188 (5), 1183\u20131194 (2018).","journal-title":"Am. J. Pathol."},{"key":"45564_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nut.2016.09.010","volume":"34","author":"SM Ostojic","year":"2017","unstructured":"Ostojic, S. M. Tackling guanidinoacetic acid for advanced cellular bioenergetics. Nutrition 34, 55\u201357 (2017).","journal-title":"Nutrition"},{"issue":"6","key":"45564_CR34","doi-asserted-by":"publisher","first-page":"F1799","DOI":"10.1152\/ajprenal.00356.2007","volume":"293","author":"EE Edison","year":"2007","unstructured":"Edison, E. E., Brosnan, M. E., Meyer, C. & Brosnan, J. T. Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo. Am. J. Physiology-Renal Physiol. 293 (6), F1799\u2013F1804 (2007).","journal-title":"Am. J. Physiology-Renal Physiol."},{"issue":"4","key":"45564_CR35","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/ndt\/gfm793","volume":"23","author":"YEC Taes","year":"2007","unstructured":"Taes, Y. E. C. et al. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol. Dialysis Transplantation. 23 (4), 1330\u20131335 (2007).","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"8","key":"45564_CR36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/JIM.0000000000000212","volume":"63","author":"SM Ostojic","year":"2015","unstructured":"Ostojic, S. M., Stojanovic, M. D. & Hoffman, J. R. Six-Week Oral Guanidinoacetic Acid Administration Improves Muscular Performance in Healthy Volunteers. J. Investig. Med. 63 (8), 942\u2013946 (2015).","journal-title":"J. Investig. Med."},{"issue":"4","key":"45564_CR37","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/fsn3.3201","volume":"11","author":"SM Ostojic","year":"2023","unstructured":"Ostojic, S. M. & Jorga, J. Guanidinoacetic acid in human nutrition: Beyond creatine synthesis. Food Sci. Nutr. 11 (4), 1606\u20131611 (2023).","journal-title":"Food Sci. Nutr."},{"issue":"1","key":"45564_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s42255-019-0159-z","volume":"2","author":"V Papalazarou","year":"2020","unstructured":"Papalazarou, V. et al. The creatine\u2013phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis. Nat. Metabolism. 2 (1), 62\u201380 (2020).","journal-title":"Nat. Metabolism"},{"issue":"8","key":"45564_CR39","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/ijc.32028","volume":"145","author":"F Mussai","year":"2019","unstructured":"Mussai, F. et al. Targeting the arginine metabolic brake enhances immunotherapy for leukaemia. Int. J. Cancer. 145 (8), 2201\u20132208 (2019).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"45564_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmet.2021.01.018","volume":"33","author":"OA Maguire","year":"2021","unstructured":"Maguire, O. A. et al. Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer. Cell Metabol. 33 (3), 499\u2013512e496 (2021).","journal-title":"Cell Metabol."},{"key":"45564_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2021.06.020","volume":"519","author":"I Novita Sari","year":"2021","unstructured":"Novita Sari, I. et al. Metabolism and function of polyamines in cancer progression. Cancer Lett. 519, 91\u2013104 (2021).","journal-title":"Cancer Lett."},{"issue":"1","key":"45564_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13105-019-00716-1","volume":"76","author":"H Wang","year":"2019","unstructured":"Wang, H., Li, Q-F., Chow, H. Y., Choi, S. C. & Leung, Y-C. Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1\/9. J. Physiol. Biochem. 76 (1), 73\u201383 (2019).","journal-title":"J. Physiol. Biochem."},{"issue":"1","key":"45564_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/CM9.0000000000001216","volume":"134","author":"J-S Yang","year":"2021","unstructured":"Yang, J-S., Wang, C-C., Qiu, J-D., Ren, B. & You, L. Arginine metabolism: a potential target in pancreatic cancer therapy. Chin. Med. J. 134 (1), 28\u201337 (2021).","journal-title":"Chin. Med. J."},{"issue":"6","key":"45564_CR44","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cmet.2021.03.009","volume":"33","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. Creatine promotes cancer metastasis through activation of Smad2\/3. Cell Metabol. 33 (6), 1111\u20131123e1114 (2021).","journal-title":"Cell Metabol."},{"key":"45564_CR45","doi-asserted-by":"crossref","unstructured":"Ostojic, S. M. Human gut microbiota as a source of guanidinoacetic acid. Medical Hypotheses 142. (2020).","DOI":"10.1016\/j.mehy.2020.109745"},{"issue":"11","key":"45564_CR46","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s10096-017-3026-4","volume":"36","author":"R Gao","year":"2017","unstructured":"Gao, R. et al. Mucosa-associated microbiota signature in colorectal cancer. Eur. J. Clin. Microbiol. Infect. Dis. 36 (11), 2073\u20132083 (2017).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"45564_CR47","doi-asserted-by":"crossref","unstructured":"Mohammadi, M., Mirzaei, H. & Motallebi, M. The role of anaerobic bacteria in the development and prevention of colorectal cancer: A review study. Anaerobe 73. (2022).","DOI":"10.1016\/j.anaerobe.2021.102501"},{"issue":"1","key":"45564_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-020117-043559","volume":"15","author":"W Van Treuren","year":"2020","unstructured":"Van Treuren, W. & Dodd, D. Microbial Contribution to the Human Metabolome: Implications for Health and Disease. Annu. Rev. Pathol. 15 (1), 345\u2013369 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"45564_CR49","doi-asserted-by":"crossref","unstructured":"An, H. J. et al. Tumor-associated microbiome features of metastatic colorectal cancer and clinical implications. Frontiers Oncology 13. (2024).","DOI":"10.3389\/fonc.2023.1310054"},{"issue":"6","key":"45564_CR50","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice. Nat. Microbiol. 9 (6), 1467\u20131482 (2024).","journal-title":"Nat. Microbiol."},{"issue":"10","key":"45564_CR51","doi-asserted-by":"publisher","first-page":"244","DOI":"10.14715\/cmb\/2023.69.10.36","volume":"69","author":"Z Yuchao","year":"2023","unstructured":"Yuchao, Z., Kaihu, F., Linping, L., Jialun, H. & Ying, S. Peptostreptococcus anaerobius is a potential diagnostic biomarker of colorectal cancer. Cell. Mol. Biol. 69 (10), 244\u2013247 (2023).","journal-title":"Cell. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45564-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:29:37Z","timestamp":1781566177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45564"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45564-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Institutional Review Committee of the Provincial Hospital Affiliated to Shandong First Medical University (ethical number SWYX: NO.2024\u2009\u2212\u2009761). Written informed consent was obtained from all participants. All methods were performed in accordance with the relevant institutional ethical committee guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"18604"}}